Citadel Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.3M | Buy |
113,500
+37,100
| +49% | +$3.4M | ﹤0.01% | 3218 |
|
|
2025
Q4 | $6.87M | Sell |
76,400
-10,200
| -12% | -$967K | ﹤0.01% | 3792 |
|
|
2025
Q3 | $8.53M | Buy |
86,600
+17,300
| +25% | +$1.71M | ﹤0.01% | 3499 |
|
|
2025
Q2 | $6.32M | Sell |
69,300
-71,000
| -51% | -$6.87M | ﹤0.01% | 3723 |
|
|
2025
Q1 | $15.9M | Buy |
140,300
+9,800
| +8% | +$1.05M | ﹤0.01% | 2296 |
|
|
2024
Q4 | $13.8M | Sell |
130,500
-2,100
| -2% | -$225K | ﹤0.01% | 2577 |
|
|
2024
Q3 | $14.3M | Buy |
132,600
+21,200
| +19% | +$2.31M | ﹤0.01% | 2433 |
|
|
2024
Q2 | $12.1M | Buy |
111,400
+10,000
| +10% | +$1.18M | ﹤0.01% | 2540 |
|
|
2024
Q1 | $13.4M | Sell |
101,400
-98,700
| -49% | -$12.3M | ﹤0.01% | 2549 |
|
|
2023
Q4 | $24.4M | Buy |
200,100
+130,500
| +188% | +$14.6M | ﹤0.01% | 1816 |
|
|
2023
Q3 | $7.81M | Sell |
69,600
-23,400
| -25% | -$2.97M | ﹤0.01% | 2999 |
|
|
2023
Q2 | $13.5M | Buy |
93,000
+63,200
| +212% | +$8.59M | ﹤0.01% | 2303 |
|
|
2023
Q1 | $3.85M | Sell |
29,800
-8,800
| -23% | -$1.1M | ﹤0.01% | 4240 |
|
|
2022
Q4 | $4.92M | Sell |
38,600
-157,900
| -80% | -$18.3M | ﹤0.01% | 3894 |
|
|
2022
Q3 | $20.5M | Buy |
196,500
+67,500
| +52% | +$7.41M | ﹤0.01% | 1851 |
|
|
2022
Q2 | $13.6M | Sell |
129,000
-90,100
| -41% | -$10.7M | ﹤0.01% | 2291 |
|
|
2022
Q1 | $28M | Sell |
219,100
-33,662
| -13% | -$4.06M | 0.01% | 1619 |
|
|
2021
Q4 | $31.2M | Buy |
252,762
+172,525
| +215% | +$22.6M | 0.01% | 1562 |
|
|
2021
Q3 | $11.4M | Buy |
80,237
+25,853
| +48% | +$3.8M | ﹤0.01% | 2842 |
|
|
2021
Q2 | $8.49M | Sell |
54,384
-44,805
| -45% | -$7.26M | ﹤0.01% | 3365 |
|
|
2021
Q1 | $15.4M | Buy |
99,189
+41,509
| +72% | +$6.43M | ﹤0.01% | 2325 |
|
|
2020
Q4 | $8.63M | Sell |
57,680
-63,654
| -52% | -$8.99M | ﹤0.01% | 2839 |
|
|
2020
Q3 | $16M | Sell |
121,334
-48,204
| -28% | -$6.3M | ﹤0.01% | 1770 |
|
|
2020
Q2 | $19.6M | Buy |
169,538
+124,939
| +280% | +$14.4M | 0.01% | 1516 |
|
|
2020
Q1 | $4.38M | Buy |
44,599
+16,995
| +62% | +$2.23M | ﹤0.01% | 2909 |
|
|
2019
Q4 | $4.01M | Sell |
27,604
-56,135
| -67% | -$7.75M | ﹤0.01% | 3373 |
|
|
2019
Q3 | $11.2M | Buy |
83,739
+27,398
| +49% | +$3.54M | 0.01% | 2088 |
|
|
2019
Q2 | $6.44M | Sell |
56,341
-233,913
| -81% | -$27.4M | ﹤0.01% | 2736 |
|
|
2019
Q1 | $36M | Buy |
290,254
+237,415
| +449% | +$27M | 0.02% | 881 |
|
|
2018
Q4 | $5.32M | Sell |
52,839
-21,527
| -29% | -$2.42M | ﹤0.01% | 2693 |
|
|
2018
Q3 | $9.49M | Buy |
74,366
+23,896
| +47% | +$2.84M | ﹤0.01% | 2157 |
|
|
2018
Q2 | $5.46M | Buy |
50,470
+1,854
| +4% | +$202K | ﹤0.01% | 2644 |
|
|
2018
Q1 | $5.15M | Buy |
48,616
+25,544
| +111% | +$2.97M | ﹤0.01% | 2422 |
|
|
2017
Q4 | $2.7M | Sell |
23,072
-6,283
| -21% | -$710K | ﹤0.01% | 3232 |
|
|
2017
Q3 | $3.34M | Sell |
29,355
-1,133
| -4% | -$131K | ﹤0.01% | 2766 |
|
|
2017
Q2 | $3.8M | Buy |
30,488
+5,150
| +20% | +$611K | ﹤0.01% | 2412 |
|
|
2017
Q1 | $3M | Sell |
25,338
-30,385
| -55% | -$3.44M | ﹤0.01% | 2578 |
|
|
2016
Q4 | $5.58M | Buy |
55,723
+22,763
| +69% | +$2.44M | 0.01% | 1886 |
|
|
2016
Q3 | $4.16M | Sell |
32,960
-5,253
| -14% | -$649K | ﹤0.01% | 2162 |
|
|
2016
Q2 | $4.47M | Sell |
38,213
-15,862
| -29% | -$1.8M | 0.01% | 1918 |
|
|
2016
Q1 | $5.6M | Buy |
54,075
+26,162
| +94% | +$2.53M | 0.01% | 1658 |
|
|
2015
Q4 | $2.78M | Buy |
27,913
+2,472
| +10% | +$242K | ﹤0.01% | 2411 |
|
|
2015
Q3 | $2.32M | Sell |
25,441
-22,351
| -47% | -$2.24M | ﹤0.01% | 2762 |
|
|
2015
Q2 | $5.07M | Buy |
47,792
+15,759
| +49% | +$1.74M | ﹤0.01% | 2055 |
|
|
2015
Q1 | $3.65M | Buy |
32,033
+16,274
| +103% | +$1.86M | ﹤0.01% | 2363 |
|
|
2014
Q4 | $1.74M | Sell |
15,759
-4,738
| -23% | -$499K | ﹤0.01% | 3087 |
|
|
2014
Q3 | $2M | Sell |
20,497
-3,296
| -14% | -$324K | ﹤0.01% | 2851 |
|
|
2014
Q2 | $2.4M | Buy |
23,793
+13,493
| +131% | +$1.32M | ﹤0.01% | 2551 |
|
|
2014
Q1 | $946K | Sell |
10,300
-15,759
| -60% | -$1.45M | ﹤0.01% | 3499 |
|
|
2013
Q4 | $2.36M | Buy |
26,059
+4,635
| +22% | +$401K | ﹤0.01% | 2378 |
|
|
2013
Q3 | $1.71M | Sell |
21,424
-6,283
| -23% | -$495K | ﹤0.01% | 2563 |
|
|
2013
Q2 | $2.02M | Buy |
+27,707
| New | +$2.07M | ﹤0.01% | 2487 |
|
Other funds holding ZBH
VCM
VPM
Citadel Advisors's ZBH Position: Q1 2026 in Review
Citadel Advisors increased its Zimmer Biomet (ZBH) stake by 320% in Q1 2026, buying an estimated $96.4M and bringing the position to 1,378,665 shares worth $125M. The position accounts for 0.02% of the portfolio, ranked #676.
Citadel Advisors first reported a position in ZBH in Q2 2013 and has held it in 49 quarters since. The position peaked at $297M in Q4 2022. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Citadel Advisors held 1,378,665 shares of Zimmer Biomet worth $125M as of Q1 2026.
- Citadel Advisors bought 1,050,289 Zimmer Biomet shares in Q1 2026, an estimated $96.4M.
- Zimmer Biomet made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #676 holding.
- Citadel Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 49 quarters since.
- Citadel Advisors's Zimmer Biomet position peaked at $297M in Q4 2022.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.